Propofol-Ketamine in Dogs & Cats
Generic: Propofol/Ketamine
Propofol-Ketamine, often referred to as 'Ketofol,' is a synergistic intravenous induction agent combination used in veterinary medicine to facilitate rapid, smooth anesthetic induction and provide cardiovascular stability.
This medication is intended for dogs and cats.
Overview
Propofol-Ketamine is a clinical mixture of the hypnotic agent propofol and the dissociative anesthetic Ketamine (Anesthetic). This combination is widely utilized by veterinary anesthesiologists to achieve a balanced anesthetic plane, leveraging the rapid onset and short duration of propofol alongside the analgesic properties of ketamine. By blending these two substances, practitioners can often lower the total dosage required for each individual component, potentially reducing the dose-dependent respiratory depression associated with higher concentrations of Alfaxalone or propofol alone. Historically, this approach has become a preferred alternative to older agents like Thiopental or Methohexital due to its cleaner recovery profile and superior titration capabilities in both dogs and cats.
In a clinical setting, the primary objective of this combination is to provide a smooth transition into maintenance anesthesia, which is typically sustained using inhalants like Isoflurane or Sevoflurane. Unlike other injectable options such as Etomidate, which is chosen specifically for its cardiovascular safety, the Propofol-Ketamine mix allows for a more versatile approach to induction that is particularly useful for patients requiring a degree of preemptive pain management. Furthermore, for procedures where brief immobilization is needed, this combination is often safer and more predictable than utilizing Tiletamine-Zolazepam (Telazol), which can lead to prolonged and sometimes dysphoric recoveries in certain canine breeds.
The use of Propofol-Ketamine is typically reserved for controlled, in-hospital environments where the veterinary team has full access to monitoring equipment and emergency resuscitation protocols. In complex cases, it may be preceded by pre-anesthetic medications like Buprenorphine (Anesthetic) or Dexmedetomidine (Anesthetic) to further dampen the sympathetic response. While not as common as using a benzodiazepine like Diazepam (Anesthetic) with ketamine, the 'Ketofol' approach remains a staple for clinicians prioritizing a high degree of control over induction quality and duration.
What It Treats
- Anesthetic Induction: Facilitates the transition from consciousness to general anesthesia.
- Pain Management: Provides peri-operative analgesia due to the N-methyl-D-aspartate (NMDA) receptor antagonism provided by ketamine.
- Brief Immobilization: Useful for short diagnostic procedures that do not require full intubation or inhalant gas.
How It Works
Propofol acts primarily as a positive allosteric modulator of GABA-A receptors, which produces rapid sedation, hypnosis, and loss of consciousness by enhancing the inhibitory effects of GABA in the central nervous system. Ketamine works as an antagonist at the NMDA receptors, preventing the perception of pain signals and causing a state of 'dissociative anesthesia' where the patient may appear conscious but is detached from sensory stimuli. When combined, the two drugs provide a synergistic effect. Propofol counteracts the potential excitatory or convulsive side effects occasionally seen with ketamine alone, while ketamine helps to mitigate the profound dose-dependent hypotension and bradycardia typically induced by propofol. This balance results in a more hemodynamically stable patient during the critical phase of induction.
Dosage
Dosage is highly variable and depends on the patient's age, health status, and concurrent medications. Typically, a 1:1 ratio is prepared, but veterinarians often adjust the proportions based on the patient's cardiovascular profile. Always follow the specific instructions provided by your attending veterinarian, as miscalculation of these potent agents can lead to respiratory arrest or severe circulatory collapse.
Administration
This mixture is administered via slow intravenous injection by a trained veterinary professional. The rate of injection is carefully titrated to the effect, with the clinician monitoring the patient's jaw tone and reflexes to determine when the appropriate plane of anesthesia has been achieved. Because of the risk of apnea, equipment for endotracheal intubation and oxygen supplementation must be immediately available during the administration process.
Storage
Propofol solutions are prone to bacterial growth and must be stored according to strict guidelines. Once a vial is opened, it should be used immediately or discarded within a few hours to prevent contamination. The combined mixture should be kept in a cool, dry place away from direct sunlight, though ideally, individual components should be mixed just prior to use to ensure chemical stability.
Contraindications
Propofol-Ketamine should be avoided in patients with severe liver or kidney disease, as the metabolism and excretion of both components are heavily reliant on these organ systems. It is also contraindicated in animals with known hypersensitivity to either propofol or ketamine, or in patients with elevated intracranial pressure or severe cardiac arrhythmias. Additionally, extreme caution should be exercised when administering this combination to patients with a history of seizures or those undergoing diagnostic procedures related to the central nervous system, as ketamine can lower the seizure threshold. Patients with pre-existing severe cardiovascular disease must be screened carefully, as the combination may cause dangerous fluctuations in blood pressure despite the stabilizing effects of the combined agents.
Interactions
Propofol-Ketamine interacts with a wide range of central nervous system depressants. Concurrent administration with phenothiazines (e.g., acepromazine), opioids, or alpha-2 agonists can cause profound respiratory depression and significantly prolonged recovery times. When used in conjunction with inhalant anesthetics, the requirement for those inhalants is generally reduced, necessitating careful monitoring of anesthetic depth. Furthermore, drugs that alter liver enzyme metabolism, such as certain barbiturates or chloramphenicol, can inhibit the clearance of these agents, leading to prolonged anesthetic effects. It is vital that the veterinarian is made aware of all supplements and medications the animal is currently receiving to avoid adverse drug-drug interactions.
Side Effects
- Apnea (temporary cessation of breathing)
- Hypotension (low blood pressure)
- Muscle twitching or myoclonus
- Increased salivation
- Bradycardia (slow heart rate)
- Injection site discomfort
- Recovery dysphoria or excitement
Sources & References
Frequently Asked Questions
This information is educational only and not a substitute for professional veterinary advice. Always consult a licensed veterinarian before starting or changing any medication.
